Michael Joseph Golembiewski - 30 Mar 2023 Form 4 Insider Report for SEELOS THERAPEUTICS, INC.

Role
Chief Financial Officer
Signature
/s/ Michael Golembiewski
Issuer symbol
N/A
Transactions as of
30 Mar 2023
Net transactions value
$0
Form type
4
Filing time
31 Mar 2023, 17:06:59 UTC
Previous filing
02 Mar 2023
Next filing
01 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +677,701 $0.000000 677,701 30 Mar 2023 Common Stock 677,701 $0.6900 Direct F1
transaction SEEL Stock Option (right to buy) Award $0 +88,030 $0.000000 88,030 30 Mar 2023 Common Stock 88,030 $0.6900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the option shall vest on March 30, 2024, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
F2 The Reporting Person voluntarily elected to be paid 35% of his 2022 annual cash bonus in the form of an option to purchase shares of common stock of the Issuer.